CD9 mRNA modifications involving deletions or missense mutations have been found in a small percentage of prostate cancer patients and some prostate cancer cell lines, with CD9 protein not detected in the majority of these cases [4]. The gene discussed is CD9; the disease is prostate carcinoma.